Medicilon Founder Chen Chunlin: An Interview With PharmAsia News

PharmAsia News' China Bureau recently spoke with Chen Chunlin, founder of Shanghai-based Medicilon, about the advantages and disadvantages for Western companies seeking partnerships with Chinese firms to conduct preclinical research, and the growth of Medicilon since its founding in 2003. U.S.-based MPI Research and Medicilon recently entered a joint venture to establish a preclinical research center in Shanghai that meets U.S. FDA and other international regulatory standards (PharmAsia News, Jan. 2, 2008)